Ombitasvir, Paritaprevir, and Ritonavir and Pasireotide Subcutaneous
Determining the interaction of Ombitasvir, Paritaprevir, and Ritonavir and Pasireotide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ombitasvir / paritaprevir / ritonavir
Brand name: Technivie
Synonyms: n.a.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, and Ritonavir-Patanase
- Ombitasvir, Paritaprevir, and Ritonavir-Patiromer
- Ombitasvir, Paritaprevir, and Ritonavir-Patiromer Sorbitex Calcium
- Ombitasvir, Paritaprevir, and Ritonavir-Pavacot
- Ombitasvir, Paritaprevir, and Ritonavir-Paxil
- Ombitasvir, Paritaprevir, and Ritonavir-Paxil (Paroxetine Suspension)
- Pasireotide Subcutaneous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Pasireotide Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Pasireotide Subcutaneous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Pasireotide Subcutaneous-Omeclamox-Pak
- Pasireotide Subcutaneous-Omega-3 Fatty Acid Capsules
- Pasireotide Subcutaneous-Omega-3 Fatty Acids